Genomic-based high throughput screening identifies small molecules that differentially inhibit the antiviral and immunomodulatory effects of IFN-alpha.
about
High throughput screening for small molecule enhancers of the interferon signaling pathway to drive next-generation antiviral drug discoverySuppression of Autoimmune Arthritis by Small Molecule Inhibitors of the JAK/STAT Pathway.HCMV utilizes a non-traditional STAT1 activation cascade via signaling through EGFR and integrins to efficiently promote the motility, differentiation, and polarization of infected monocytes.
P2860
Genomic-based high throughput screening identifies small molecules that differentially inhibit the antiviral and immunomodulatory effects of IFN-alpha.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Genomic-based high throughput ...... dulatory effects of IFN-alpha.
@ast
Genomic-based high throughput ...... dulatory effects of IFN-alpha.
@en
Genomic-based high throughput ...... dulatory effects of IFN-alpha.
@nl
type
label
Genomic-based high throughput ...... dulatory effects of IFN-alpha.
@ast
Genomic-based high throughput ...... dulatory effects of IFN-alpha.
@en
Genomic-based high throughput ...... dulatory effects of IFN-alpha.
@nl
prefLabel
Genomic-based high throughput ...... dulatory effects of IFN-alpha.
@ast
Genomic-based high throughput ...... dulatory effects of IFN-alpha.
@en
Genomic-based high throughput ...... dulatory effects of IFN-alpha.
@nl
P2093
P2860
P356
P1433
P1476
Genomic-based high throughput ...... dulatory effects of IFN-alpha.
@en
P2093
Anna Glodek
Anthony J Coyle
Brian Naiman
Chad Morris
Dan Soppet
Derong Liu
Gary P Sims
Juana Castaneda
Laurent Audoly
P2860
P2888
P304
P356
10.2119/2008-00028.CHEN
P407
P577
2008-07-01T00:00:00Z
P6179
1068965079